ANDREA BRILES: Open Payments
NPI 1770528374 · NASHVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 6 companies in 2025. Trend: 2023 $387 · 2024 $119 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $94 |
| Novo Nordisk Inc | 3 | $79 |
| Organon LLC | 4 | $69 |
| ABBVIE INC. | 2 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| COLOPLAST CORP | 1 | $18 |
Products named: MYFEMBREE, NEXPLANON, Wegovy, Exparel, Altis, LO LOESTRIN FE, QULIPTA.
Industry payments across IL — which companies pay providers there.
